Novel toll-like receptor 4 (TLR4) antagonists identified by structure- and ligand-based virtual screening

European Journal of Medicinal Chemistry

Volumn 70, Issue , 2013, Pages 393-399

  Švajger, Urban ^a   Brus, Boris ^b   Turk, Samo ^b   Sova, Matej ^b   Hodnik, Vesna ^b   Anderluh, Gregor ^b,c   Gobec, Stanislav ^b  

^a BLOOD TRANSFUSION CENTRE OF SLOVENIA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c NATIONAL INSTITUTE OF CHEMISTRY   (Slovenia)

Author keywords

Docking; Surface plasmon resonance; TLR4 antagonist; Toll like receptor 4; Virtual screening

Indexed keywords

ERITORAN; RESATORVID; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG IDENTIFICATION; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MOLECULAR RECOGNITION; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; SURFACE PLASMON RESONANCE; VIRTUAL REALITY;

DOCKING; HEK293; HUMAN EMBRYONIC KIDNEY 293 CELLS; LIPOPOLYSACCHARIDE; LPS; MD-2; MYELOID DIFFERENTIATION FACTOR 2; PAMPS; PATHOGEN-ASSOCIATED MOLECULAR PATTERNS; PATTERN-RECOGNITION RECEPTOR; PBMCS; PERIPHERAL BLOOD MONONUCLEAR CELLS; PPI; PPRS; PROTEIN-PROTEIN INTERACTION; SEAP; SECRETED EMBRYONIC ALKALINE PHOSPHATASE; SPR; SURFACE PLASMON RESONANCE; TLR4; TLR4 ANTAGONIST; TNF-Α; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-Α; VIRTUAL SCREENING;

CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HEK293 CELLS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; LEUKOCYTES, MONONUCLEAR; LIGANDS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; SMALL MOLECULE LIBRARIES; SOLUBILITY; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE PLASMON RESONANCE; TOLL-LIKE RECEPTOR 4;

EID: 84886549484     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2013.10.019     Document Type: Article

References (23)

1. T. Kawai, and S. Akira Toll-like receptors and their crosstalk with other innate receptors in infection and immunity Immunity 34 2011 637 650
2. S. Akira, S. Uematsu, and O. Takeuchi Pathogen recognition and innate immunity Cell 124 2006 783 801 (Pubitemid 43261452)
3. T. Kawai, and S. Akira Innate immune recognition of viral infection Nat. Immunol. 7 2006 131 137 (Pubitemid 43135878)
4. X. Wittebole, D. Castanares-Zapatero, and P.F. Laterre Toll-like receptor 4 modulation as a strategy to treat sepsis Mediators Inflammation 2010 2010
5. L. Guo, and H. Schluesener The innate immunity of the central nervous system in chronic pain: the role of toll-like receptors Cell Mol. Life Sci. 64 2007 1128 1136 (Pubitemid 46684548)
6. A. Barochia, S. Solomon, X. Cui, C. Natanson, and P.Q. Eichacker Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studies Expert Opin. Drug Metab. Toxicol. 7 2011 479 494
7. T.W. Rice, A.P. Wheeler, G.R. Bernard, J.-L. Vincent, D.C. Angus, and N. Aikawa A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis Crit. Care Med. 38 2010 1685 1694
8. N. Matsunaga, N. Tsuchimori, T. Matsumoto, and M. Ii TAK-242 (resatorvid), a small-molecule inhibitor of toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules Mol. Pharmacol. 79 2011 34 41
9. H.M. Kim, B.S. Park, J.-I. Kim, S.E. Kim, J. Lee, and S.C. Oh Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist eritoran Cell(Cambridge, Mass.) 130 2007 906 917 (Pubitemid 47332573)
10. Q.C. Zhang, D. Petrey, L. Deng, L. Qiang, Y. Shi, and C.A. Thu Structure-based prediction of protein-protein interactions on a genome-wide scale Nature 490 2012 556 560
11. L.-G. Milroy, L. Brunsveld, and C. Ottmann Stabilization and inhibition of protein-protein interactions: the 14-3-3 case study ACS Chem. Biol. 8 2013 27 35
12. A. Mullard Protein-protein interaction inhibitors get into the groove Nat. Rev. Drug Discov. 11 2012 173 175
13. B.S. Park, D.H. Song, H.M. Kim, B.-S. Choi, H. Lee, and J.-O. Lee The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex Nature 458 2009 1191 1195
14. J. Han, H.J. Kim, S.-C. Lee, S. Hong, K. Park, and Y.H. Jeon Structure-based rational design of a toll-like receptor 4 (TLR4) decoy receptor with high binding affinity for a target protein PLoS ONE. 7 2012 e30929
15. S.A. Chavez, A.J. Martinko, C. Lau, M.N. Pham, K. Cheng, and D.E. Bevan Development of β-amino alcohol derivatives that inhibit toll-like receptor 4 mediated inflammatory response as potential antiseptics J. Med. Chem. 54 2011 4659 4669
16. J.J. Irwin, T. Sterling, M.M. Mysinger, E.S. Bolstad, and R.G. Coleman ZINC: a free tool to discover chemistry for biology J. Chem. Inf. Model 52 2012 1757 1768
17. P.C.D. Hawkins, A.G. Skillman, G.L. Warren, B.A. Ellingson, and M.T. Stahl Conformer generation with OMEGA: algorithm and validation using high quality structures from the protein databank and Cambridge structural database J. Chem. Inf. Model 50 2010 572 584
18. P.C.D. Hawkins, and A. Nicholls Conformer generation with OMEGA: learning from the data set and the analysis of failures J. Chem. Inf. Model 52 2012 2919 2936
19. M. Rarey, B. Kramer, T. Lengauer, and G. Klebe A fast flexible docking method using an incremental construction algorithm J. Mol. Biol. 261 1996 470 489 (Pubitemid 26335901)
20. C. Joce, J.A. Stahl, M. Shridhar, M.R. Hutchinson, L.R. Watkins, and P.O. Fedichev Application of a novel in silico high throughput screen to identify selective inhibitors for protein-protein interactions Bioorg. Med. Chem. Lett. 20 2010 5411 5413
21. D.E. Bevan, A.J. Martinko, L.C. Loram, J.A. Stahl, F.R. Taylor, and S. Joshee Selection, preparation, and evaluation of small-molecule inhibitors of toll-like receptor 4 ACS Med. Chem. Lett. 1 2010 194 198
22. A. Nicholls, G.B. McGaughey, R.P. Sheridan, A.C. Good, G. Warren, and M. Mathieu Molecular shape and medicinal chemistry: a perspective J. Med. Chem. 53 2010 3862 3886
23. E. Dahlén, K. Dawe, L. Ohlsson, and G. Hedlund Dendritic cells and macrophages are the first and major producers of TNF-alpha in pancreatic islets in the nonobese diabetic mouse J. Immunol. 160 1998 3585 3593 (Pubitemid 28164755)